Prosecution Insights
Last updated: August 14, 2026

University of Iowa Research Foundation

19 pending office actions • 13 art units • 18 examiners • 0 of 19 (0%) have an AI response strategy ready • 23 patents granted in the last 365 days

Portfolio Summary

19
Total Pending OAs
11
Non-Final OAs
7
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
1
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (1)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (26%)
12
Medium (63%)
2
Easy (11%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only7 (37%)
§102 only2 (11%)
§112 only1 (5%)
Double-patenting only1 (5%)
Double-patenting + other3 (16%)
Multi-statute (no §101)5 (26%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

11
Life Sciences
58% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
21% of docket
4
Business / Other
21% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAK, JOHN D 2 52.2% +37.6%
ROBLES, EILEEN 1
HUH, VYNN V 1 61.2% +44.0%
DONOHUE, SEAN R 1 41.4% +21.1%
RONEY, CELESTE A 1 62.8% +17.7%
MCMILLIAN, KARA RENITA 1 30.4% +37.9%
CROW, ROBERT THOMAS 1 41.7% +32.1%
SHIAO, REI TSANG 1 79.8% -33.7%
WESTERBERG, NISSA M 1 23.3% +36.8%
MEYERING, SHABANA SHABBEER 1 69.7% +41.8%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17796311 Modular Remote Afterloader For Brachytherapy Delivery And Cartridge For Same KOHUTKA, BROOKE NICOLE 49d overdue
18031760 PROCESSES FOR SYNTHESIS OF ALPHA-EMITTING RADIOPHARMACEUTICALS WESTERBERG, NISSA M 53d
18024034 DITHIOPHOSPHATE DERIVATIVES AS HYDROGEN SULFIDE RELEASE CHEMICALS FOR IMPROVING PLANT GROWTH AND CROP YIELD PAK, JOHN D 53d
18870291 LOW ENERGY, NON-FERROUS, NON-MAGNETIC DRIVING SYSTEM FOR MEDICAL AND OTHER APPLICATIONS ROBLES, EILEEN
18262970 CONFORMATIONALLY-CONSTRAINED INHIBITORS OF 3C OR 3C-LIKE PROTEASES MCMILLIAN, KARA RENITA
18032768 METHODS FOR IMPROVING PLANT GROWTH AND CROP YIELD BY USING COMPOUNDS OF TRISULPHIDE OR TETRASULPHIDE PAK, JOHN D

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18223765 OPTOELECTRONIC CARTRIDGE FOR CANCER BIOMARKER DETECTION UTILIZING SILICON NANOWIRE ARRAYS CROW, ROBERT THOMAS 16d overdue
18031760 PROCESSES FOR SYNTHESIS OF ALPHA-EMITTING RADIOPHARMACEUTICALS WESTERBERG, NISSA M 53d
18024034 DITHIOPHOSPHATE DERIVATIVES AS HYDROGEN SULFIDE RELEASE CHEMICALS FOR IMPROVING PLANT GROWTH AND CROP YIELD PAK, JOHN D 53d
18957458 CONTROLLED POSITION ELECTRODE ARRAY HUH, VYNN V
18896069 COMPOSITIONS FOR CHELATING METALS AT LOW TEMPERATURES DONOHUE, SEAN R
18886316 GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS RONEY, CELESTE A
18262970 CONFORMATIONALLY-CONSTRAINED INHIBITORS OF 3C OR 3C-LIKE PROTEASES MCMILLIAN, KARA RENITA
18032768 METHODS FOR IMPROVING PLANT GROWTH AND CROP YIELD BY USING COMPOUNDS OF TRISULPHIDE OR TETRASULPHIDE PAK, JOHN D

Top Art Units

Art UnitApps
1618 2
1699 2
3791 2
3792 1
1623 1
1683 1
1691 1
1635 1
4100 1
1626 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18870291 LOW ENERGY, NON-FERROUS, NON-MAGNETIC DRIVING SYSTEM FOR MEDICAL AND OTHER APPLICATIONS ROBLES, EILEEN §102§103 Non-Final OA Pending Nov 27, 2024
18957458 CONTROLLED POSITION ELECTRODE ARRAY HUH, VYNN V 3792 §103Other Non-Final OA Pending Nov 22, 2024
18896069 COMPOSITIONS FOR CHELATING METALS AT LOW TEMPERATURES DONOHUE, SEAN R 1618 §102§103§112DP Non-Final OA Pending Sep 25, 2024
18886316 GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS RONEY, CELESTE A DP Non-Final OA Pending Sep 16, 2024
18262970 CONFORMATIONALLY-CONSTRAINED INHIBITORS OF 3C OR 3C-LIKE PROTEASES MCMILLIAN, KARA RENITA 1623 §103§112 Non-Final OA Pending Jul 26, 2023
18223765 OPTOELECTRONIC CARTRIDGE FOR CANCER BIOMARKER DETECTION UTILIZING SILICON NANOWIRE ARRAYS CROW, ROBERT THOMAS 1683 §103DP Final Rejection 16d overdue Pending Jul 19, 2023
18347192 METHODS OF TREATING CYSTIC FIBROSIS USING WITH-NO-LYSINE (WNK) KINASE PATHWAY INHIBITORS SHIAO, REI TSANG 1691 §103 Final Rejection 42d overdue Pending Jul 05, 2023
18032768 METHODS FOR IMPROVING PLANT GROWTH AND CROP YIELD BY USING COMPOUNDS OF TRISULPHIDE OR TETRASULPHIDE PAK, JOHN D 1699 §102§103§112 Non-Final OA Pending Apr 19, 2023
18031760 PROCESSES FOR SYNTHESIS OF ALPHA-EMITTING RADIOPHARMACEUTICALS WESTERBERG, NISSA M 1618 §103 Non-Final OA 53d Pending Apr 13, 2023
18120204 MICRORNA INHIBITOR SYSTEM AND METHODS OF USE THEREOF MEYERING, SHABANA SHABBEER 1635 §112 Non-Final OA Pending Mar 10, 2023
18024034 DITHIOPHOSPHATE DERIVATIVES AS HYDROGEN SULFIDE RELEASE CHEMICALS FOR IMPROVING PLANT GROWTH AND CROP YIELD PAK, JOHN D 1699 §102§103Other Non-Final OA 53d Pending Feb 28, 2023
18175371 Forecasting method for flood crest magnitude and arrival time LU, QIANG 4100 §103 Non-Final OA Pending Feb 27, 2023
18107108 COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS LEITH, NANCY J §103DP Non-Final OA Pending Feb 08, 2023
18017826 INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES MELLITUS PATEL, SAGAR S 1626 §102 Final Rejection Pending Jan 24, 2023
17984575 PRODUCTION SYSTEM FOR HELPER-DEPENDENT ADENOVIRUS GU, QINHUA 1633 §103 Final Rejection Pending Nov 10, 2022
17796311 Modular Remote Afterloader For Brachytherapy Delivery And Cartridge For Same KOHUTKA, BROOKE NICOLE 3791 §102§103 Final Rejection 49d overdue Pending Jul 29, 2022
17563929 APPARATUS, SYSTEMS AND METHODS FOR ERGONOMIC MEDICAL PROCEDURES GEIGER, RACHAEL L 3771 §103 Final Rejection 22d Pending Dec 28, 2021
17518301 MULTIMODAL SENSORY STIMULATION TRAN, JULIE THI 3791 §103 Non-Final OA 52d overdue Pending Nov 03, 2021
17311088 HEPARANASE INHIBITORS AND THEIR USE AS ANTI-CANCER COMPOUNDS SABILA, MERCY HELLEN 1654 §102Other Final Rejection 18d overdue Pending Jun 04, 2021

Managing University of Iowa Research Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month